"Drugs Show Promise In Fighting Breast, Lung, And Prostate Cancers"
Several drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There's even a "uni-drug" that may fight many forms of the disease. What's especially striking: The drugs are beneficial in some cases for more than a year, much longer than the few months many new drugs provide. Stephen Malamud, MD, associate professor of medical oncology at the Icahn School of Medicine at Mount Sinai talks about a drug called Xeloda, which can extend the lives of some women whose breast cancer is not wiped out by standard treatment.
- Stephen Malamud, MD, Associate Professor, Medicine, Hematology, Medical Oncology, Icahn School of Medicine at Mount Sinai
Mount Sinai Study Finds Lung Cancer Surgery Safe for Many Patients Over 80
Apr 02, 2026 View All Press Releases
Mount Sinai’s Alison Snow, PhD, MSW, Named 2026 Oncology Social Worker of the Year
Mar 24, 2026 View All Press Releases
Mount Sinai Study May Help Cancer Patients Keep Their Bladder
Feb 19, 2026 View All Press Releases
